Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
Enovis Corporation (NYSE: ENOV), a medical technology growth company, will host a conference call and webcast to discuss its second quarter 2025 financial results on Thursday, August 7th, 2025, at 8:30 a.m. ET. The company will release its earnings report earlier that morning.
Investors can access the live webcast through Enovis' website investor section, and those wishing to participate in the call can dial (833) 685-0901. A presentation and replay of the call will be available on the company's website following the event.
Enovis Corporation (NYSE: ENOV), un'azienda in crescita nel settore della tecnologia medica, terr脿 una conference call e una diretta webcast per discutere i risultati finanziari del secondo trimestre 2025 il gioved矛 7 agosto 2025, alle 8:30 a.m. ET. La societ脿 pubblicher脿 il rapporto sugli utili nella stessa mattinata.
Gli investitori potranno seguire la diretta webcast tramite la sezione investor del sito web di Enovis, mentre chi desidera partecipare alla chiamata pu貌 chiamare il numero (833) 685-0901. Una presentazione e la registrazione della chiamata saranno disponibili sul sito web aziendale dopo l'evento.
Enovis Corporation (NYSE: ENOV), una empresa de tecnolog铆a m茅dica en crecimiento, realizar谩 una conferencia telef贸nica y una transmisi贸n en vivo para discutir los resultados financieros del segundo trimestre de 2025 el jueves 7 de agosto de 2025 a las 8:30 a.m. ET. La compa帽铆a publicar谩 su informe de ganancias esa misma ma帽ana.
Los inversionistas pueden acceder a la transmisi贸n en vivo a trav茅s de la secci贸n de inversores en el sitio web de Enovis, y quienes deseen participar en la llamada pueden marcar el (833) 685-0901. Una presentaci贸n y la repetici贸n de la llamada estar谩n disponibles en el sitio web de la empresa despu茅s del evento.
Enovis Corporation (NYSE: ENOV)鞚� 鞚橂 旮办垹 靹膘灔 旮办梾鞙茧靹� 2025雲� 2攵勱赴 鞛 鞁れ爜鞚� 雲检潣頃橁赴 鞙勴暣 2025雲� 8鞗� 7鞚� 氇╈殧鞚� 鞓れ爠 8鞁� 30攵�(霃欕秬鞁滉皠)鞐� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� 臧欖潃 雮� 鞎勳龚 鞚检皪 鞁れ爜 氤搓碃靹滊ゼ 氚滍憸頃� 瓴冹瀰雼堧嫟.
韴瀽鞛愲摛鞚� Enovis 鞗轨偓鞚错姼鞚� 韴瀽鞛� 靹轨厴鞚� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 鞝勴檾 彀胳棳毳� 鞗愴晿電� 瓴届毎 (833) 685-0901搿� 鞝勴檾頃橂┐ 霅╇媹雼�. 氚滍憸 鞛愲鞕� 旖� 雲轨潓鞚� 頄夓偓 頉� 須岇偓 鞗轨偓鞚错姼鞐愳劀 鞝滉车霅� 鞓堨爼鞛呺媹雼�.
Enovis Corporation (NYSE : ENOV), une entreprise en croissance dans le domaine de la technologie m茅dicale, organisera une conf茅rence t茅l茅phonique et une webdiffusion pour discuter des r茅sultats financiers du deuxi猫me trimestre 2025 le jeudi 7 ao没t 2025 脿 8h30 (heure de l'Est). La soci茅t茅 publiera son rapport sur les r茅sultats plus t么t dans la matin茅e.
Les investisseurs peuvent acc茅der 脿 la webdiffusion en direct via la section investisseurs du site web d'Enovis, et ceux qui souhaitent participer 脿 l'appel peuvent composer le (833) 685-0901. Une pr茅sentation et le replay de l'appel seront disponibles sur le site web de la soci茅t茅 apr猫s l'茅v茅nement.
Enovis Corporation (NYSE: ENOV), ein wachsendes Medizintechnikunternehmen, wird eine Telefonkonferenz und einen Webcast veranstalten, um die Finanzergebnisse des zweiten Quartals 2025 am Donnerstag, den 7. August 2025, um 8:30 Uhr ET zu besprechen. Das Unternehmen wird seinen Gewinnbericht bereits am selben Morgen ver枚ffentlichen.
Investoren k枚nnen den Live-Webcast 眉ber den Investor-Bereich der Enovis-Website verfolgen, und wer am Anruf teilnehmen m枚chte, kann die Nummer (833) 685-0901 w盲hlen. Eine Pr盲sentation und eine Aufzeichnung des Anrufs werden nach der Veranstaltung auf der Unternehmenswebsite verf眉gbar sein.
- None.
- None.
Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis鈩� Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2025 financial results on Thursday, August 7th, 2025, at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the "Investors" section of Enovis' website at .
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901. A replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company鈥檚 extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company鈥檚 shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit聽.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares at ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
FAQ
When will Enovis (NYSE: ENOV) report Q2 2025 earnings?
How can investors access the Enovis Q2 2025 earnings call?
Will there be a replay available of the Enovis Q2 2025 earnings call?
What materials will be available for Enovis' Q2 2025 earnings call?
